1. Home
  2. OCFT vs CTXR Comparison

OCFT vs CTXR Comparison

Compare OCFT & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCFT
  • CTXR
  • Stock Information
  • Founded
  • OCFT 2015
  • CTXR 2007
  • Country
  • OCFT China
  • CTXR United States
  • Employees
  • OCFT N/A
  • CTXR N/A
  • Industry
  • OCFT Computer Software: Programming Data Processing
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • OCFT Technology
  • CTXR Health Care
  • Exchange
  • OCFT Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • OCFT 93.6M
  • CTXR 84.9M
  • IPO Year
  • OCFT 2019
  • CTXR N/A
  • Fundamental
  • Price
  • OCFT $2.30
  • CTXR $0.41
  • Analyst Decision
  • OCFT Strong Buy
  • CTXR Strong Buy
  • Analyst Count
  • OCFT 1
  • CTXR 2
  • Target Price
  • OCFT $7.00
  • CTXR $5.00
  • AVG Volume (30 Days)
  • OCFT 333.2K
  • CTXR 1.1M
  • Earning Date
  • OCFT 11-11-2024
  • CTXR 08-12-2024
  • Dividend Yield
  • OCFT N/A
  • CTXR N/A
  • EPS Growth
  • OCFT N/A
  • CTXR N/A
  • EPS
  • OCFT N/A
  • CTXR N/A
  • Revenue
  • OCFT $447,273,527.00
  • CTXR N/A
  • Revenue This Year
  • OCFT N/A
  • CTXR N/A
  • Revenue Next Year
  • OCFT N/A
  • CTXR N/A
  • P/E Ratio
  • OCFT N/A
  • CTXR N/A
  • Revenue Growth
  • OCFT N/A
  • CTXR N/A
  • 52 Week Low
  • OCFT $0.87
  • CTXR $0.34
  • 52 Week High
  • OCFT $4.98
  • CTXR $1.07
  • Technical
  • Relative Strength Index (RSI)
  • OCFT 50.07
  • CTXR 38.61
  • Support Level
  • OCFT $2.20
  • CTXR $0.34
  • Resistance Level
  • OCFT $4.98
  • CTXR $0.41
  • Average True Range (ATR)
  • OCFT 0.62
  • CTXR 0.04
  • MACD
  • OCFT -0.11
  • CTXR 0.00
  • Stochastic Oscillator
  • OCFT 6.62
  • CTXR 36.59

About OCFT OneConnect Financial Technology Co. Ltd.

OneConnect Financial Technology Co Ltd is a provider of technology platforms. Its platform provides cloud-native technology solutions that integrate financial services with market technology. The company offers technology applications and technology-enabled business services to financial institutions in China. Its technology solutions cover multiple verticals in the financial services industry, including banking, insurance and asset management, across the full scope of their businesses from sales and marketing and risk management to customer services and operations, as well as technology infrastructures such as data management and cloud services. The firm operates in two segments namely Technology Solutions which is the key revenue driver and Virtual Bank Business.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.

Share on Social Networks: